Thursday, March 15, 2018 2:40:29 PM
The Division cited testimony from DBMM regarding investments of $61,000 and $250,000, expected by the company, which is going to give it the capital needed to get current with its filings. The Division then made the argument that DBMM had to “rely on the kindness of strangers to give it money....”. Does the Division not understand the distinction between charity and investment? Does the Division truly believe that some generous person is simply handing DBMM significant money? In fact, the very fact that someone is willing to invest so heavily in DBMM is a pretty good indication that DBMM is not a shell without a future.
In two places, the Division simply called DBMM’s claims meritless without providing any support for that statement. In one instance, the attorney simply claims that the Division was unable to find any support or explanation for DBMM’s argument. Not finding a case or other legal analysis performed by another person does not excuse a lack of briefing the issue. In another instance, the Division cites a case that BDMM relied on but argued that the case was inapplicable to this case. The Division provided no support for that statement or even an explanation regarding the issues presented in that case and why it was inapplicable. Conclusory statements without support do not bolster an argument.
Go DBMM. Keep fighting.
The link to the post trial brief is below:
https://www.sec.gov/litigation/apdocuments/3-17990-event-64.pdf
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM